Related Experiment Videos

Can a vitamin prevent hepatocellular carcinoma?

¹Division of Hematology / Oncology, University of California, San Francisco, USA.

Hepatology (Baltimore, Md.)

|January 1, 1997

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

ESMO open·2025

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

British journal of cancer·2013

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.

British journal of cancer·2005

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

Hepatocellular carcinoma.

Current treatment options in oncology·2002

See all related articles